Global Peramivir Market Research Report 2020
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Peramivir market is segmented into
The Peramivir market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Peramivir market report are:
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Peramivir market include:
Segment by Type, the Peramivir market is segmented into
- Solution
- Solid
- Influenza A Treatment
- Influenza B Treatment
The Peramivir market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Peramivir market report are:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Peramivir market include:
- BioCryst Pharmaceuticals
- Green Cross Pharma
- Shionogi Co.
- NeoPharm
- Moksha8 Pharma
- NT Pharma
- Merck
- Hikma Pharmaceuticals
- Hunan Nucien Pharmaceutical Co., Ltd.
- SCOLR Pharma
1 PERAMIVIR MARKET OVERVIEW
1.1 Product Overview and Scope of Peramivir
1.2 Peramivir Segment by Type
1.2.1 Global Peramivir Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Solution
1.2.3 Solid
1.3 Peramivir Segment by Application
1.3.1 Peramivir Sales Comparison by Application: 2020 VS 2026
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Global Peramivir Market Size Estimates and Forecasts
1.4.1 Global Peramivir Revenue 2015-2026
1.4.2 Global Peramivir Sales 2015-2026
1.4.3 Peramivir Market Size by Region: 2020 Versus 2026
1.5 Peramivir Industry
1.6 Peramivir Market Trends
2 GLOBAL PERAMIVIR MARKET COMPETITION BY MANUFACTURERS
2.1 Global Peramivir Sales Market Share by Manufacturers (2015-2020)
2.2 Global Peramivir Revenue Share by Manufacturers (2015-2020)
2.3 Global Peramivir Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Peramivir Manufacturing Sites, Area Served, Product Type
2.5 Peramivir Market Competitive Situation and Trends
2.5.1 Peramivir Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Peramivir Players (Opinion Leaders)
3 PERAMIVIR RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Peramivir Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Peramivir Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Peramivir Market Facts & Figures by Country
3.3.1 North America Peramivir Sales by Country
3.3.2 North America Peramivir Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Peramivir Market Facts & Figures by Country
3.4.1 Europe Peramivir Sales by Country
3.4.2 Europe Peramivir Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Peramivir Market Facts & Figures by Region
3.5.1 Asia Pacific Peramivir Sales by Region
3.5.2 Asia Pacific Peramivir Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Peramivir Market Facts & Figures by Country
3.6.1 Latin America Peramivir Sales by Country
3.6.2 Latin America Peramivir Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Peramivir Market Facts & Figures by Country
3.7.1 Middle East and Africa Peramivir Sales by Country
3.7.2 Middle East and Africa Peramivir Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 GLOBAL PERAMIVIR HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Peramivir Sales Market Share by Type (2015-2020)
4.2 Global Peramivir Revenue Market Share by Type (2015-2020)
4.3 Global Peramivir Price Market Share by Type (2015-2020)
4.4 Global Peramivir Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL PERAMIVIR HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Peramivir Sales Market Share by Application (2015-2020)
5.2 Global Peramivir Revenue Market Share by Application (2015-2020)
5.3 Global Peramivir Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN PERAMIVIR BUSINESS
6.1 BioCryst Pharmaceuticals
6.1.1 Corporation Information
6.1.2 BioCryst Pharmaceuticals Description, Business Overview and Total Revenue
6.1.3 BioCryst Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.1.4 BioCryst Pharmaceuticals Products Offered
6.1.5 BioCryst Pharmaceuticals Recent Development
6.2 Green Cross Pharma
6.2.1 Green Cross Pharma Corporation Information
6.2.2 Green Cross Pharma Description, Business Overview and Total Revenue
6.2.3 Green Cross Pharma Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Green Cross Pharma Products Offered
6.2.5 Green Cross Pharma Recent Development
6.3 Shionogi Co.
6.3.1 Shionogi Co. Corporation Information
6.3.2 Shionogi Co. Description, Business Overview and Total Revenue
6.3.3 Shionogi Co. Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Shionogi Co. Products Offered
6.3.5 Shionogi Co. Recent Development
6.4 NeoPharm
6.4.1 NeoPharm Corporation Information
6.4.2 NeoPharm Description, Business Overview and Total Revenue
6.4.3 NeoPharm Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.4.4 NeoPharm Products Offered
6.4.5 NeoPharm Recent Development
6.5 Moksha8 Pharma
6.5.1 Moksha8 Pharma Corporation Information
6.5.2 Moksha8 Pharma Description, Business Overview and Total Revenue
6.5.3 Moksha8 Pharma Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Moksha8 Pharma Products Offered
6.5.5 Moksha8 Pharma Recent Development
6.6 NT Pharma
6.6.1 NT Pharma Corporation Information
6.6.2 NT Pharma Description, Business Overview and Total Revenue
6.6.3 NT Pharma Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.6.4 NT Pharma Products Offered
6.6.5 NT Pharma Recent Development
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description, Business Overview and Total Revenue
6.6.3 Merck Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merck Products Offered
6.7.5 Merck Recent Development
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Corporation Information
6.8.2 Hikma Pharmaceuticals Description, Business Overview and Total Revenue
6.8.3 Hikma Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Hikma Pharmaceuticals Products Offered
6.8.5 Hikma Pharmaceuticals Recent Development
6.9 Hunan Nucien Pharmaceutical Co., Ltd.
6.9.1 Hunan Nucien Pharmaceutical Co., Ltd. Corporation Information
6.9.2 Hunan Nucien Pharmaceutical Co., Ltd. Description, Business Overview and Total Revenue
6.9.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hunan Nucien Pharmaceutical Co., Ltd. Products Offered
6.9.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Development
6.10 SCOLR Pharma
6.10.1 SCOLR Pharma Corporation Information
6.10.2 SCOLR Pharma Description, Business Overview and Total Revenue
6.10.3 SCOLR Pharma Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.10.4 SCOLR Pharma Products Offered
6.10.5 SCOLR Pharma Recent Development
7 PERAMIVIR MANUFACTURING COST ANALYSIS
7.1 Peramivir Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Peramivir
7.4 Peramivir Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Peramivir Distributors List
8.3 Peramivir Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Peramivir Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Peramivir by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Peramivir by Type (2021-2026)
10.2 Peramivir Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Peramivir by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Peramivir by Application (2021-2026)
10.3 Peramivir Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Peramivir by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Peramivir by Region (2021-2026)
10.4 North America Peramivir Estimates and Projections (2021-2026)
10.5 Europe Peramivir Estimates and Projections (2021-2026)
10.6 Asia Pacific Peramivir Estimates and Projections (2021-2026)
10.7 Latin America Peramivir Estimates and Projections (2021-2026)
10.8 Middle East and Africa Peramivir Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Peramivir
1.2 Peramivir Segment by Type
1.2.1 Global Peramivir Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Solution
1.2.3 Solid
1.3 Peramivir Segment by Application
1.3.1 Peramivir Sales Comparison by Application: 2020 VS 2026
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Global Peramivir Market Size Estimates and Forecasts
1.4.1 Global Peramivir Revenue 2015-2026
1.4.2 Global Peramivir Sales 2015-2026
1.4.3 Peramivir Market Size by Region: 2020 Versus 2026
1.5 Peramivir Industry
1.6 Peramivir Market Trends
2 GLOBAL PERAMIVIR MARKET COMPETITION BY MANUFACTURERS
2.1 Global Peramivir Sales Market Share by Manufacturers (2015-2020)
2.2 Global Peramivir Revenue Share by Manufacturers (2015-2020)
2.3 Global Peramivir Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Peramivir Manufacturing Sites, Area Served, Product Type
2.5 Peramivir Market Competitive Situation and Trends
2.5.1 Peramivir Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Peramivir Players (Opinion Leaders)
3 PERAMIVIR RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Peramivir Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Peramivir Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Peramivir Market Facts & Figures by Country
3.3.1 North America Peramivir Sales by Country
3.3.2 North America Peramivir Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Peramivir Market Facts & Figures by Country
3.4.1 Europe Peramivir Sales by Country
3.4.2 Europe Peramivir Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Peramivir Market Facts & Figures by Region
3.5.1 Asia Pacific Peramivir Sales by Region
3.5.2 Asia Pacific Peramivir Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Peramivir Market Facts & Figures by Country
3.6.1 Latin America Peramivir Sales by Country
3.6.2 Latin America Peramivir Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Peramivir Market Facts & Figures by Country
3.7.1 Middle East and Africa Peramivir Sales by Country
3.7.2 Middle East and Africa Peramivir Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 GLOBAL PERAMIVIR HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Peramivir Sales Market Share by Type (2015-2020)
4.2 Global Peramivir Revenue Market Share by Type (2015-2020)
4.3 Global Peramivir Price Market Share by Type (2015-2020)
4.4 Global Peramivir Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL PERAMIVIR HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Peramivir Sales Market Share by Application (2015-2020)
5.2 Global Peramivir Revenue Market Share by Application (2015-2020)
5.3 Global Peramivir Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN PERAMIVIR BUSINESS
6.1 BioCryst Pharmaceuticals
6.1.1 Corporation Information
6.1.2 BioCryst Pharmaceuticals Description, Business Overview and Total Revenue
6.1.3 BioCryst Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.1.4 BioCryst Pharmaceuticals Products Offered
6.1.5 BioCryst Pharmaceuticals Recent Development
6.2 Green Cross Pharma
6.2.1 Green Cross Pharma Corporation Information
6.2.2 Green Cross Pharma Description, Business Overview and Total Revenue
6.2.3 Green Cross Pharma Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Green Cross Pharma Products Offered
6.2.5 Green Cross Pharma Recent Development
6.3 Shionogi Co.
6.3.1 Shionogi Co. Corporation Information
6.3.2 Shionogi Co. Description, Business Overview and Total Revenue
6.3.3 Shionogi Co. Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Shionogi Co. Products Offered
6.3.5 Shionogi Co. Recent Development
6.4 NeoPharm
6.4.1 NeoPharm Corporation Information
6.4.2 NeoPharm Description, Business Overview and Total Revenue
6.4.3 NeoPharm Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.4.4 NeoPharm Products Offered
6.4.5 NeoPharm Recent Development
6.5 Moksha8 Pharma
6.5.1 Moksha8 Pharma Corporation Information
6.5.2 Moksha8 Pharma Description, Business Overview and Total Revenue
6.5.3 Moksha8 Pharma Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Moksha8 Pharma Products Offered
6.5.5 Moksha8 Pharma Recent Development
6.6 NT Pharma
6.6.1 NT Pharma Corporation Information
6.6.2 NT Pharma Description, Business Overview and Total Revenue
6.6.3 NT Pharma Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.6.4 NT Pharma Products Offered
6.6.5 NT Pharma Recent Development
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description, Business Overview and Total Revenue
6.6.3 Merck Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merck Products Offered
6.7.5 Merck Recent Development
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Corporation Information
6.8.2 Hikma Pharmaceuticals Description, Business Overview and Total Revenue
6.8.3 Hikma Pharmaceuticals Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Hikma Pharmaceuticals Products Offered
6.8.5 Hikma Pharmaceuticals Recent Development
6.9 Hunan Nucien Pharmaceutical Co., Ltd.
6.9.1 Hunan Nucien Pharmaceutical Co., Ltd. Corporation Information
6.9.2 Hunan Nucien Pharmaceutical Co., Ltd. Description, Business Overview and Total Revenue
6.9.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hunan Nucien Pharmaceutical Co., Ltd. Products Offered
6.9.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Development
6.10 SCOLR Pharma
6.10.1 SCOLR Pharma Corporation Information
6.10.2 SCOLR Pharma Description, Business Overview and Total Revenue
6.10.3 SCOLR Pharma Peramivir Sales, Revenue and Gross Margin (2015-2020)
6.10.4 SCOLR Pharma Products Offered
6.10.5 SCOLR Pharma Recent Development
7 PERAMIVIR MANUFACTURING COST ANALYSIS
7.1 Peramivir Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Peramivir
7.4 Peramivir Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Peramivir Distributors List
8.3 Peramivir Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Peramivir Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Peramivir by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Peramivir by Type (2021-2026)
10.2 Peramivir Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Peramivir by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Peramivir by Application (2021-2026)
10.3 Peramivir Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Peramivir by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Peramivir by Region (2021-2026)
10.4 North America Peramivir Estimates and Projections (2021-2026)
10.5 Europe Peramivir Estimates and Projections (2021-2026)
10.6 Asia Pacific Peramivir Estimates and Projections (2021-2026)
10.7 Latin America Peramivir Estimates and Projections (2021-2026)
10.8 Middle East and Africa Peramivir Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global Peramivir Sales (Kilotons) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Peramivir Sales (Kilotons) Comparison by Application: 2020 VS 2026
Table 3. Global Peramivir Market Size by Type (Kilotons) (US$ Million) (2020 VS 2026)
Table 4. Global Key Peramivir Manufacturers Covered in This Study
Table 5. Global Peramivir Sales (Kilotons) by Manufacturers (2015-2020)
Table 6. Global Peramivir Sales Share by Manufacturers (2015-2020)
Table 7. Global Peramivir Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Peramivir Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Peramivir Average Price (US$/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Peramivir Sales Sites and Area Served
Table 11. Manufacturers Peramivir Product Types
Table 12. Global Peramivir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Peramivir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peramivir as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Peramivir Players
Table 16. Global Peramivir Sales (Kilotons) by Region (2015-2020)
Table 17. Global Peramivir Sales Market Share by Region (2015-2020)
Table 18. Global Peramivir Revenue (Million US$) by Region (2015-2020)
Table 19. Global Peramivir Revenue Market Share by Region (2015-2020)
Table 20. North America Peramivir Sales by Country (2015-2020) (Kilotons)
Table 21. North America Peramivir Sales Market Share by Country (2015-2020)
Table 22. North America Peramivir Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Peramivir Revenue Market Share by Country (2015-2020)
Table 24. Europe Peramivir Sales by Country (2015-2020) (Kilotons)
Table 25. Europe Peramivir Sales Market Share by Country (2015-2020)
Table 26. Europe Peramivir Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Peramivir Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Peramivir Sales by Region (2015-2020) (Kilotons)
Table 29. Asia Pacific Peramivir Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Peramivir Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Peramivir Revenue Market Share by Region (2015-2020)
Table 32. Latin America Peramivir Sales by Country (2015-2020) (Kilotons)
Table 33. Latin America Peramivir Sales Market Share by Country (2015-2020)
Table 34. Latin America Peramivir Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Peramivir Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Peramivir Sales by Country (2015-2020) (Kilotons)
Table 37. Middle East and Africa Peramivir Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Peramivir Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Peramivir Revenue Market Share by Country (2015-2020)
Table 40. Global Peramivir Sales (Kilotons) by Type (2015-2020)
Table 41. Global Peramivir Sales Share by Type (2015-2020)
Table 42. Global Peramivir Revenue (Million US$) by Type (2015-2020)
Table 43. Global Peramivir Revenue Share by Type (2015-2020)
Table 44. Global Peramivir Price (US$/Kg) by Type (2015-2020)
Table 45. Global Peramivir Sales (Kilotons) by Application (2015-2020)
Table 46. Global Peramivir Sales Market Share by Application (2015-2020)
Table 47. Global Peramivir Sales Growth Rate by Application (2015-2020)
Table 48. BioCryst Pharmaceuticals Peramivir Corporation Information
Table 49. BioCryst Pharmaceuticals Description and Business Overview
Table 50. BioCryst Pharmaceuticals Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 51. BioCryst Pharmaceuticals Main Product
Table 52. BioCryst Pharmaceuticals Recent Development
Table 53. Green Cross Pharma Peramivir Corporation Information
Table 54. Green Cross Pharma Corporation Information
Table 55. Green Cross Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 56. Green Cross Pharma Main Product
Table 57. Green Cross Pharma Recent Development
Table 58. Shionogi Co. Peramivir Corporation Information
Table 59. Shionogi Co. Corporation Information
Table 60. Shionogi Co. Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 61. Shionogi Co. Main Product
Table 62. Shionogi Co. Recent Development
Table 63. NeoPharm Peramivir Corporation Information
Table 64. NeoPharm Corporation Information
Table 65. NeoPharm Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 66. NeoPharm Main Product
Table 67. NeoPharm Recent Development
Table 68. Moksha8 Pharma Peramivir Corporation Information
Table 69. Moksha8 Pharma Corporation Information
Table 70. Moksha8 Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 71. Moksha8 Pharma Main Product
Table 72. Moksha8 Pharma Recent Development
Table 73. NT Pharma Peramivir Corporation Information
Table 74. NT Pharma Corporation Information
Table 75. NT Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 76. NT Pharma Main Product
Table 77. NT Pharma Recent Development
Table 78. Merck Peramivir Corporation Information
Table 79. Merck Corporation Information
Table 80. Merck Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 81. Merck Main Product
Table 82. Merck Recent Development
Table 83. Hikma Pharmaceuticals Peramivir Corporation Information
Table 84. Hikma Pharmaceuticals Corporation Information
Table 85. Hikma Pharmaceuticals Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 86. Hikma Pharmaceuticals Main Product
Table 87. Hikma Pharmaceuticals Recent Development
Table 88. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Corporation Information
Table 89. Hunan Nucien Pharmaceutical Co., Ltd. Corporation Information
Table 90. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 91. Hunan Nucien Pharmaceutical Co., Ltd. Main Product
Table 92. Hunan Nucien Pharmaceutical Co., Ltd. Recent Development
Table 93. SCOLR Pharma Peramivir Corporation Information
Table 94. SCOLR Pharma Corporation Information
Table 95. SCOLR Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 96. SCOLR Pharma Main Product
Table 97. SCOLR Pharma Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Peramivir Distributors List
Table 101. Peramivir Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Peramivir Sales (Kilotons) Forecast by Type (2021-2026)
Table 106. Global Peramivir Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Peramivir Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Peramivir Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Peramivir Sales (Kilotons) Forecast by Application (2021-2026)
Table 110. Global Peramivir Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Peramivir Sales (Kilotons) Forecast by Region (2021-2026)
Table 112. Global Peramivir Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Peramivir Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Peramivir Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 1. Global Peramivir Sales (Kilotons) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Peramivir Sales (Kilotons) Comparison by Application: 2020 VS 2026
Table 3. Global Peramivir Market Size by Type (Kilotons) (US$ Million) (2020 VS 2026)
Table 4. Global Key Peramivir Manufacturers Covered in This Study
Table 5. Global Peramivir Sales (Kilotons) by Manufacturers (2015-2020)
Table 6. Global Peramivir Sales Share by Manufacturers (2015-2020)
Table 7. Global Peramivir Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Peramivir Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Peramivir Average Price (US$/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Peramivir Sales Sites and Area Served
Table 11. Manufacturers Peramivir Product Types
Table 12. Global Peramivir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Peramivir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peramivir as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Peramivir Players
Table 16. Global Peramivir Sales (Kilotons) by Region (2015-2020)
Table 17. Global Peramivir Sales Market Share by Region (2015-2020)
Table 18. Global Peramivir Revenue (Million US$) by Region (2015-2020)
Table 19. Global Peramivir Revenue Market Share by Region (2015-2020)
Table 20. North America Peramivir Sales by Country (2015-2020) (Kilotons)
Table 21. North America Peramivir Sales Market Share by Country (2015-2020)
Table 22. North America Peramivir Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Peramivir Revenue Market Share by Country (2015-2020)
Table 24. Europe Peramivir Sales by Country (2015-2020) (Kilotons)
Table 25. Europe Peramivir Sales Market Share by Country (2015-2020)
Table 26. Europe Peramivir Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Peramivir Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Peramivir Sales by Region (2015-2020) (Kilotons)
Table 29. Asia Pacific Peramivir Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Peramivir Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Peramivir Revenue Market Share by Region (2015-2020)
Table 32. Latin America Peramivir Sales by Country (2015-2020) (Kilotons)
Table 33. Latin America Peramivir Sales Market Share by Country (2015-2020)
Table 34. Latin America Peramivir Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Peramivir Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Peramivir Sales by Country (2015-2020) (Kilotons)
Table 37. Middle East and Africa Peramivir Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Peramivir Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Peramivir Revenue Market Share by Country (2015-2020)
Table 40. Global Peramivir Sales (Kilotons) by Type (2015-2020)
Table 41. Global Peramivir Sales Share by Type (2015-2020)
Table 42. Global Peramivir Revenue (Million US$) by Type (2015-2020)
Table 43. Global Peramivir Revenue Share by Type (2015-2020)
Table 44. Global Peramivir Price (US$/Kg) by Type (2015-2020)
Table 45. Global Peramivir Sales (Kilotons) by Application (2015-2020)
Table 46. Global Peramivir Sales Market Share by Application (2015-2020)
Table 47. Global Peramivir Sales Growth Rate by Application (2015-2020)
Table 48. BioCryst Pharmaceuticals Peramivir Corporation Information
Table 49. BioCryst Pharmaceuticals Description and Business Overview
Table 50. BioCryst Pharmaceuticals Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 51. BioCryst Pharmaceuticals Main Product
Table 52. BioCryst Pharmaceuticals Recent Development
Table 53. Green Cross Pharma Peramivir Corporation Information
Table 54. Green Cross Pharma Corporation Information
Table 55. Green Cross Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 56. Green Cross Pharma Main Product
Table 57. Green Cross Pharma Recent Development
Table 58. Shionogi Co. Peramivir Corporation Information
Table 59. Shionogi Co. Corporation Information
Table 60. Shionogi Co. Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 61. Shionogi Co. Main Product
Table 62. Shionogi Co. Recent Development
Table 63. NeoPharm Peramivir Corporation Information
Table 64. NeoPharm Corporation Information
Table 65. NeoPharm Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 66. NeoPharm Main Product
Table 67. NeoPharm Recent Development
Table 68. Moksha8 Pharma Peramivir Corporation Information
Table 69. Moksha8 Pharma Corporation Information
Table 70. Moksha8 Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 71. Moksha8 Pharma Main Product
Table 72. Moksha8 Pharma Recent Development
Table 73. NT Pharma Peramivir Corporation Information
Table 74. NT Pharma Corporation Information
Table 75. NT Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 76. NT Pharma Main Product
Table 77. NT Pharma Recent Development
Table 78. Merck Peramivir Corporation Information
Table 79. Merck Corporation Information
Table 80. Merck Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 81. Merck Main Product
Table 82. Merck Recent Development
Table 83. Hikma Pharmaceuticals Peramivir Corporation Information
Table 84. Hikma Pharmaceuticals Corporation Information
Table 85. Hikma Pharmaceuticals Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 86. Hikma Pharmaceuticals Main Product
Table 87. Hikma Pharmaceuticals Recent Development
Table 88. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Corporation Information
Table 89. Hunan Nucien Pharmaceutical Co., Ltd. Corporation Information
Table 90. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 91. Hunan Nucien Pharmaceutical Co., Ltd. Main Product
Table 92. Hunan Nucien Pharmaceutical Co., Ltd. Recent Development
Table 93. SCOLR Pharma Peramivir Corporation Information
Table 94. SCOLR Pharma Corporation Information
Table 95. SCOLR Pharma Peramivir Sales (Kilotons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 96. SCOLR Pharma Main Product
Table 97. SCOLR Pharma Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Peramivir Distributors List
Table 101. Peramivir Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Peramivir Sales (Kilotons) Forecast by Type (2021-2026)
Table 106. Global Peramivir Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Peramivir Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Peramivir Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Peramivir Sales (Kilotons) Forecast by Application (2021-2026)
Table 110. Global Peramivir Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Peramivir Sales (Kilotons) Forecast by Region (2021-2026)
Table 112. Global Peramivir Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Peramivir Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Peramivir Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Peramivir
Figure 2. Global Peramivir Sales Market Share by Type: 2020 VS 2026
Figure 3. Solution Product Picture
Figure 4. Solid Product Picture
Figure 5. Global Peramivir Consumption Market Share by Application: 2020 VS 2026
Figure 6. Influenza A Treatment
Figure 7. Influenza B Treatment
Figure 8. Global Peramivir Market Size 2015-2026 (US$ Million)
Figure 9. Global Peramivir Sales Capacity (Kilotons) (2015-2026)
Figure 10. Global Peramivir Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Peramivir Sales Share by Manufacturers in 2020
Figure 12. Global Peramivir Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Peramivir Revenue in 2019
Figure 14. Peramivir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Peramivir Sales Market Share by Region (2015-2020)
Figure 16. Global Peramivir Sales Market Share by Region in 2019
Figure 17. Global Peramivir Revenue Market Share by Region (2015-2020)
Figure 18. Global Peramivir Revenue Market Share by Region in 2019
Figure 19. North America Peramivir Sales Market Share by Country in 2019
Figure 20. North America Peramivir Revenue Market Share by Country in 2019
Figure 21. U.S. Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 22. U.S. Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 24. Canada Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Peramivir Sales Market Share by Country in 2019
Figure 26. Europe Peramivir Revenue Market Share by Country in 2019
Figure 27. Germany Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 28. Germany Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 30. France Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 32. U.K. Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 34. Italy Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 36. Russia Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Peramivir Sales Market Share by Region in 2019
Figure 38. Asia Pacific Peramivir Revenue Market Share by Region in 2019
Figure 39. China Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 40. China Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 42. Japan Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 44. South Korea Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 46. India Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 48. Australia Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 50. Taiwan Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 52. Indonesia Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 54. Thailand Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 56. Malaysia Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 58. Philippines Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 60. Vietnam Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Peramivir Sales Market Share by Country in 2019
Figure 62. Latin America Peramivir Revenue Market Share by Country in 2019
Figure 63. Mexico Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 64. Mexico Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 66. Brazil Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 68. Argentina Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Peramivir Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Peramivir Revenue Market Share by Country in 2019
Figure 71. Turkey Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 72. Turkey Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 74. Saudi Arabia Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 76. U.A.E Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Peramivir by Type (2015-2020)
Figure 78. Sales Market Share of Peramivir by Type in 2019
Figure 79. Revenue Share of Peramivir by Type (2015-2020)
Figure 80. Revenue Market Share of Peramivir by Type in 2019
Figure 81. Global Peramivir Sales Growth by Type (2015-2020) (Kilotons)
Figure 82. Global Peramivir Sales Market Share by Application (2015-2020)
Figure 83. Global Peramivir Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Peramivir by Application (2015-2020)
Figure 85. Global Revenue Share of Peramivir by Application in 2020
Figure 86. BioCryst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Green Cross Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Shionogi Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. NeoPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Moksha8 Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. NT Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Hunan Nucien Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. SCOLR Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Price Trend of Key Raw Materials
Figure 97. Manufacturing Cost Structure of Peramivir
Figure 98. Manufacturing Process Analysis of Peramivir
Figure 99. Peramivir Industrial Chain Analysis
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. North America Peramivir Sales (Kilotons) and Growth Rate Forecast (2021-2026)
Figure 104. North America Peramivir Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Peramivir Sales (Kilotons) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Peramivir Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Peramivir Sales (Kilotons) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Peramivir Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Peramivir Sales (Kilotons) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Peramivir Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Peramivir Sales (Kilotons) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Peramivir Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
Figure 1. Picture of Peramivir
Figure 2. Global Peramivir Sales Market Share by Type: 2020 VS 2026
Figure 3. Solution Product Picture
Figure 4. Solid Product Picture
Figure 5. Global Peramivir Consumption Market Share by Application: 2020 VS 2026
Figure 6. Influenza A Treatment
Figure 7. Influenza B Treatment
Figure 8. Global Peramivir Market Size 2015-2026 (US$ Million)
Figure 9. Global Peramivir Sales Capacity (Kilotons) (2015-2026)
Figure 10. Global Peramivir Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Peramivir Sales Share by Manufacturers in 2020
Figure 12. Global Peramivir Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Peramivir Revenue in 2019
Figure 14. Peramivir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Peramivir Sales Market Share by Region (2015-2020)
Figure 16. Global Peramivir Sales Market Share by Region in 2019
Figure 17. Global Peramivir Revenue Market Share by Region (2015-2020)
Figure 18. Global Peramivir Revenue Market Share by Region in 2019
Figure 19. North America Peramivir Sales Market Share by Country in 2019
Figure 20. North America Peramivir Revenue Market Share by Country in 2019
Figure 21. U.S. Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 22. U.S. Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 24. Canada Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Peramivir Sales Market Share by Country in 2019
Figure 26. Europe Peramivir Revenue Market Share by Country in 2019
Figure 27. Germany Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 28. Germany Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 30. France Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 32. U.K. Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 34. Italy Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 36. Russia Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Peramivir Sales Market Share by Region in 2019
Figure 38. Asia Pacific Peramivir Revenue Market Share by Region in 2019
Figure 39. China Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 40. China Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 42. Japan Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 44. South Korea Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 46. India Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 48. Australia Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 50. Taiwan Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 52. Indonesia Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 54. Thailand Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 56. Malaysia Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 58. Philippines Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 60. Vietnam Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Peramivir Sales Market Share by Country in 2019
Figure 62. Latin America Peramivir Revenue Market Share by Country in 2019
Figure 63. Mexico Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 64. Mexico Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 66. Brazil Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 68. Argentina Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Peramivir Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Peramivir Revenue Market Share by Country in 2019
Figure 71. Turkey Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 72. Turkey Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 74. Saudi Arabia Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Peramivir Sales Growth Rate (2015-2020) (Kilotons)
Figure 76. U.A.E Peramivir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Peramivir by Type (2015-2020)
Figure 78. Sales Market Share of Peramivir by Type in 2019
Figure 79. Revenue Share of Peramivir by Type (2015-2020)
Figure 80. Revenue Market Share of Peramivir by Type in 2019
Figure 81. Global Peramivir Sales Growth by Type (2015-2020) (Kilotons)
Figure 82. Global Peramivir Sales Market Share by Application (2015-2020)
Figure 83. Global Peramivir Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Peramivir by Application (2015-2020)
Figure 85. Global Revenue Share of Peramivir by Application in 2020
Figure 86. BioCryst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Green Cross Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Shionogi Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. NeoPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Moksha8 Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. NT Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Hunan Nucien Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. SCOLR Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Price Trend of Key Raw Materials
Figure 97. Manufacturing Cost Structure of Peramivir
Figure 98. Manufacturing Process Analysis of Peramivir
Figure 99. Peramivir Industrial Chain Analysis
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. North America Peramivir Sales (Kilotons) and Growth Rate Forecast (2021-2026)
Figure 104. North America Peramivir Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Peramivir Sales (Kilotons) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Peramivir Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Peramivir Sales (Kilotons) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Peramivir Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Peramivir Sales (Kilotons) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Peramivir Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Peramivir Sales (Kilotons) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Peramivir Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
